data13F

OCUL – Ocular Therapeutix Inc

Held by 0 of 60 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

OCUL chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Closed00.02
Q2 2026Paul Tudor Jones narrow view Reduced 14.9%522,6630.00
Q1 2026Paul Tudor Jones narrow view Added 24.2%614,3780.01
Q4 2025Paul Tudor Jones narrow view Added 205.6%494,7920.02

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Paul Tudor Jones narrow view Added 24.2%614,3780.01
Q4 2025Paul Tudor Jones narrow view Added 205.6%494,7920.02

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Closed00.02
Q2 2026Paul Tudor Jones narrow view Reduced 14.9%522,6630.00

History

1 peakQ2 2026: 1 tracked investors
Q2 2015: 1 tracked investorsQ4 2015: 1 tracked investorsQ3 2021: 1 tracked investorsQ4 2021: 1 tracked investorsQ2 2022: 1 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 1 tracked investorsQ1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ4 2023: 1 tracked investorsQ1 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investors
20152026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones–522.7K614.4K494.8K161.9K–79.6K–

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).